Additional conspiracy charge tacked onto Martin Shkreli case

Martin Shkreli, the former CEO of Retrophin and Turing Pharmaceuticals, who was made famous by a 5,000 percent price hike on a cancer and AIDS drug, now faces an additional conspiracy charge, according to The Wall Street Journal.

Advertisement

Both Mr. Shkreli and his former lawyer, Evan Greebel, were charged Friday by federal prosecutors for securities fraud conspiracy, according to the report. The charges are related to Mr. Shkreli’s control over shares of Retrophin, and his failure to disclose this information to the Securities and Exchange Commission, according to the report.

Both Mr. Shkreli and his lawyer now face eight total counts of fraud and conspiracy to commit fraud, according to a CNN Money report. Mr. Shkreli pleaded not guilty in a Brooklyn court Monday, according to the report. He is not worried about this additional charge, though he said he is preparing to learn mixed martial arts in the event he goes to prison, according to CNN Money.

 

More articles on legal and regulatory issues:

14 latest healthcare industry lawsuits, settlements
Lee Memorial wants to evict another patient
Mississippi health system to pay $150M over failed pension plan

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.